Persistence of Immunogenicity of MenACWY Conjugate Vaccine 5 Years After Childhood Vaccination, and Immune Response to a Booster Dose
Clinical trial NCT01823536 · COMPLETED
Trial details
- NCT number
- NCT01823536
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2013-10-01
- Enrollment
- 465
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.